THE AVAILABILITY OF ANTIHYPERTENSIVE DRUG IN ERA OF NHI: A STUDY IN THE PRIMARY HEALTH CARE CENTRE JAKARTA-INDONESIA by RESTINIA, MITA et al.
Restinia et al. 
Int J App Pharm, Vol 13, Special Issue 2, 2021, 93-98 
The 3rd Postgraduate Seminar on Pharmaceutical Sciences 2020              | 93 
THE AVAILABILITY OF ANTIHYPERTENSIVE DRUG IN ERA OF NHI: A STUDY IN THE 
PRIMARY HEALTH CARE CENTRE JAKARTA-INDONESIA 
Original Article 
 
MITA RESTINIA1*, DIAN RATIH LAKSMITAWATI1, YUSI ANGGRIANI1, YUDHA SEKOWATI2 
1Faculty of Pharmacy, Pancasila University, Jakarta 12640, Indonesia, 2Academy Pharmacy IKIFA, Jakarta, Indonesia 
*Email: mita_restinia@univpancasila.ac.id 
Received: 06 Sep 2020, Revised and Accepted: 08 Oct 2020 
ABSTRACT 
Objective: The study was carried out to observe the impact of NHI to availability, usage, stock of antihypertensive drug enrolled in a national 
formulary in one of the primary health care centre in Jakarta.  
Methods: A longitudinal time series design was performed retrospectively to analyse the availability, usage, and stock of antihypertensive drug. The 
data period was from January 2013 (1 y before NHI) to December 2015 (2 y after NHI). The Independent-Samples T or Mann-Whitney test was 
conducted to compare these parameters before and after NHI.  
Results: We found amlodipine 5 mg and 10 mg tablet, hydrochlorothiazide 25 mg tablet, captopril 12.5 mg and 25 mg tablet, nifedipine 10 mg tablet 
were available in Primary Health Care. These drug were generic and tablet dosage form. The most common drug used was captopril and Nifedipine, 
respectively. The highest availability was diuretic hydrochlorothiazide. The availability of amlodipine 5 mg and 10 mg tablet, captopril 12.5 mg 
tablet increased significantly (P<0.05) after NHI was implemented. Moreover, hydrochlorothiazide decreased (P<0.05) as well. The usage of 
amlodipine and hydrochlorothiazide risen (P<0.05) but the nifedipine decreased (P<0.05) after NHI. All stock of antihypertensive except captopril 
25 mg different significantly (P<0.05) after the application of NHI.  
Conclusion: This study highlights the implementation of NHI impacted the availability, usage, and stock of antihypertensive drug enrolled in 
national formulary. 
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INTRODUCTION 
The Indonesian government implemented National Health Insurance 
(NHI) known as Jaminan Kesehatan Nasional (JKN) on 1stJanuary 
2014. The aim of its implementation was to increase access and 
improve the quality of healthcare for Indonesian citizen [1]. In era of 
NHI in Indonesia, health policy has reformed, mainly the payment 
method, medicine utilization policy, and procurement.  
The government changed the payment method from fee for service 
(FFS) to the Indonesian Case Base Group (Ina-CBGs) payment 
method. Ina-CBG was system for classifying patient care adopted by 
Drug Related Group (DRG). All treatment services, including 
medicines, were covered by insurance with FFS payment method. 
However, the payment method of Ina-CBGs limited covered of 
treatment cost regarding on package rate of diagnose [2]. The 
package rate of Ina-CBGs compose the cost of doctor, administration, 
medical examination, laboratory tests, and medicines. The package 
rate for one patient’s different based on type and place of health care 
services [3].  
The guideline for utilization of medicine was different before and 
after NHI. Before the implementation of NHI, the public health care 
center requested the drug based on plafond list of price drug known 
as Daftar Plafon Harga Obat (DPHO) [4]. Meanwhile, in era of NHI 
the public health care center should demand appropriate drug based 
on National Formulary [5]. Therefore, the demand of National 
Formulary medicine will be increase.  
National Formulary contains the list of drug has created by 
government and improved continuously, mainly the prices of drug. 
The prices of National Formulary medicines are regulated under 
Presidential Decree No. 111 of 2013 [6]. The list of medicine in 
National Formulary were generic. The different finding in DPHO, 
there were available branded and generic drug. In Mexico, after the 
implementation of universal health coverage (UHC), the usage of 
generic increased and 17.3% patients did not get the medicine due 
to the limitation of drug availability [7]. Another studyIn Sudan, 
medicine usage increased significantly after the implementation of 
UHC [8] and the similar result found in Korea [9].  
Another health policy reformed after NHI implementation was the 
procurement. In era of NHI, the procurement of National Formulary 
medicine is limited by e-catalogue [10]. All public health care centers 
access e-catalogue online through an online link (https://e-katalog. 
lkpp. go. id/). Meanwhile, there is no limitation access to procure the 
medicine before NHI.  
Hypertension is one of chronic disease require long treatment and 
medicine. The availability of antihypertensive is one of parameter to 
support the success of treatment. National health survey (2014) in 
Indonesia showed the prevalence of hypertension was 25.8%. This 
percentage increased compare to the previous. The 20% people in 
metropolitan city in Indonesia have diagnosed hypertension [11].  
There are 24 antihypertensive drugs enrolled in National Formulary 
[5]. These drugs are divided some dosage forms, such as tablet, film 
coated tablet, extended coated tablet, injection, infusion. The list of 
drug in National Formulary generally consisted the drug choice for 
hypertention. The first choice antihypertensive by JNC 8 and 
European Society of Hypertension (ESH) and of the European 
Society of Cardiology (ESC) the guideline for hypertension were 
angiotensin-converting enzyme (ACEI), such as captopril, 
Angiostensin receptor blocker (ARB) as valsartan, Ca channel 
blocker (CCB) as amlodipine and nifedipine, and diuretic 
hydrochlorothiazide [12, 13]. 
The health care facilities in Indonesia are divided to the first health 
care centre, such as primary health care and secondary health care. 
All member of NHI should visit firstly to primary health care to heal 
the ailment. Furthermore, the disease was not improved in primary 
health care; the patients refer to higher health care facilities. The 
patients are not allowed directly to secondary health care centre. 
After NHI was implemented, the number of patients visit to the 
primary health care center increase significantly. In addition, the 
research on impact of NHI in primary healt care sites of Indonesia 
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are limited. Therefore this study was carried out to analyse the 
impact of NHI to the availability, usage, and stock of 
antihypertensive drug in primary health care centre in metropolitan 
city in Jakarta, Indonesia. 
MATERIALS AND METHODS 
Materials 
The planning drug supply book, the report of drug used and drug 
demand, drug stock card, drug demand and supply book, DPHO 
2011, and National Formulary were the data source in this study.  
Study design  
The availability of antihypertensive drug, drug used, and stock of 
drug was observed by longitudinal time series design study. The 
period of data was followed retrospectively was 2013 (1 y before 
NHI) to 2015 (2 y after NHI). 
Inclusion and exclusion criteria 
All antihypertensive drug found in National Formulary were 
included in this study. The uncompleted data of availability, usage, 
and stock of antihypertensive drug during data period (January 
2013 to December 2015) were excluded. 
Study indicators  
Each indicator was analyzed based on the period before and after 
the implementation of the NHI. These indicators are as follows: the 
percentage drug used per availability of antihypertensive drug, the 
availability antihypertensive drug, the usage of antihypertensive 
drug, and the stock of antihypertensive drug. 
Analysis of data 
The statistical analysis was used to understand the different all 
parameters between before and after NHI. The data normally 
distributed was analysed by Independent-Samples T test. Mann-
Whitney test was used to analyse the non-normal distribution data. 
RESULTS 
The percentage of drug used (U) and availability (A) 
Table 1 showed that the highest availability antihypertensive drug in 
primary health care centre in Jakarta was hydrochlorothiazide tablet 
(tab) 25 mg and was followed nifedipine tab 10 mg, captopril tab 
12.5 mg respectively. Meanwhile, the most frequent 
antihypertensive drug used (%U/A) was not the highest available. 
Captopril and nifedipine 10 mg were the most frequent used. The 
percentage of drug used and the availability increased after NHI 
from 23.12% to 31.14%. 
 
Table 1: The average of the availability (A) and drug used (U) of antihypertensive drug 
Kind of medicine 1 y before NHI (strip/blister) 1 y after NHI (strip/blister) 2 y after NHI (strip/blister) 
A U % U/A A U % U/A A U % U/A 
HCT tab 25 mg  4154.42 144.58 3 3068.75 292.33 10 1855.5 251.67 14 
Nifedipine tab 10 mg 2620.58 606.83 23 3210.5 522.00 16 1667.25 202.92 12 
Captopril tab 12.5 mg 2447.42 1179.25 48 3068.75 1147.00 37 3560.83 1167.25 33 
Captopril tab 25 mg 2345.00 728.92 31 3497.42 1046.42 30 1540.17 543.67 35 
Amlodipine tab 5 mg 216.00 64.83 30 566.25 262.42 46 1327.25 892.42 67 
Amlodipine tab 10 mg   478.67 189.92 40 
Total 11783.42 2724.41 23.12 13411.67 3270.17 24.38 10429.67 3247.83 31.1 
 
The statistical analysis 
Table 2 showed the result of statistical analysis of the different 
availability, usage, and stock of antihypertensive drug between 
before and after NHI in the primary health care centre site. The 
availability, usage and the stock of amlodipine 5 mg tab increased 
significantly (P<0.05). Meanwhile, there was no prescribed 
amlodipine 10 mg tab before NHI. The availability and stock of 
hydrochlorothiazide decreased (P<0.05) eventhough this medicine 
prescribed wisely after NHI. The increased of this medicine was not 
proportional with the availability and stock. Therefore, the 
availability and stock of hydrochlorothiazide were dropped after 
NHI. The availability and stock of captoprile 12.5 mg raised 
significantly (P<0.05). The different finding with the usage of this 
medicine was not different between before and after NHI. Captopril 
25 mg tab was not different statistically related its availability, usage 
and stock (P>0.05). Nifedipine tab was prescribed not frequent after 
NHI. Therefore the stock of increased significantly (P<0.05). 
 
Table 2: The statistical analysis availability, usage, and stock of antihypertensive drug 
Indicators Mean±SD Before NHI Mean±SD After NHI Sig (2 Tailed) 
Amlodipine 5 mg tab    












Amlodipine 10 mg tab    
 The availability 
The usage 










Hydrochlorothiazide 25 mg tab    












Captoprile 12.5 mg tab    






































Before: the period before was January to December 2013. After: the period after was January 2014 to December 2015. *Independent-Samples T test 
and **Mann-Whitney test. (P=95%) 
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The impact of NHI to the availability, usage, and stock of 
antihypertensive drug hydrochlorothiazide tab 25 mg  
The availability and stock of hydrochlorothiazide in the end of 1 y 
before NHI tend to be decrease until the first quarter year the 
implementation of NHI (fig. 1). The different result was found in the 
second quarter in the first-year implementation of NHI, the 
availability increased significantly until September 2014 and tend to 
be decrease in the lowest availability. Furthermore, the usage of this 
drug slightly increased after NHI implementation because the 
number of patients visit the primary health care centre increased as 
well. The statistical analysis showed the availability and stock of 
drug decreased significantly (P<0.05). 
Nifedipine tab 15 mg 
Nifedipine tab 15 mg was the second-highest available 
antihypertensive drug in the primary health care centre in Jakarta. 
Fig. 2 showed the available and stock of nifedipine rise significantly 
in the first semester NHI implemented and then fluctuated decrease 
and became stable in the second year of NHI. Furthermore, the usage 
of this tablet was not different between before and 1 y after NHI but 
slightly decreased after NHI. 
 
 
Fig. 1: Trend of the availability, usage, stock of hydrochlorothiazide tab 25 mg 
 
 
Fig. 2: Trend of the availability, usage, stock of nifedipine tab 10 mg 
 
Captopril tab 12.5 mg 
Captopril is one of the first choices drugs to treat the 
hypertension. This drug also available in primary health care. Its 
availability found increasing after NHI even fluctuated. The 
frequency of prescribe this drug was not different before and 
after NHI (fig. 3).  
Captopril tab 25 mg 
Fig. 4 showed that the usage of captopril tab 25 mg increased after 
NHI implemented. The availability decreased in the first quarter 1 y 
after NHI and became fluctuated and tend to be decreased in the 
second year of NHI. the trend of the stock of drug was similar with 
the availability. 
Amlodipine tab 5 mg 
Fig. 5 described that the availability and stock of amlodipine tab 5 
increased significantly after NHI both first and second year NHI 
implementation. The drug used found grew up significantly after NHI. 
The important finding issue was the usage of amlodipine similar with the 
availability in the September 2014. Therefore, the stock of drug was zero. 
Amlodipine tab 10 mg 
Amlodipine tab 10 mg also available in the first health care in 
metropolitan city Jakarta. This drug was not found before and the 
first year NHI because there is limitation of availability of this drug. 
The finding availability and stock of amlodipine tab 10 mg tend to be 
increased each month. 
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Fig. 3: Trend of the availability, usage, stock of captopril tab 12.5 mg 
 
 
Fig. 4: The availability, drug used, and stock of drug of captopril tab 25 mg 
 
 
Fig. 5. Trend of the availability, usage, and stock of amlodipine tab 5 mg 
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Fig. 6: Trend of the availability, usage, and stock of amlodipine tab 10 mg 
 
DISCUSSION 
There are 24 antihypertensive drugs enrolled in National Formulary 
[5]. These drugs are divided some dosage forms, such as tablet, film 
coated tablet, extended coated tablet, injection, infusion. In this 
study, we found 6 (25%) kinds of antihypertensive drug available in 
National Formulary, such as amlodipine tab 5 mg and 10 mg, 
hydrochlorothiazide tab 25 mg, captopril tab 12.5 mg and 25 mg, 
nifedipine tab 10 mg. Furthermore, during period of study, 
antihypertensive medicine was found entirely generic and tablet 
dosage form. One of the reason was the rule of the government. The 
government (The Ministry of Health) asked the public health care 
centre used the generic drug [14]. Therefore, the primary health 
care centre as publich health care prescribed antihypertensive drug 
mostly generic. In African region, 68% patients in primary health 
care centers were prescribed generic medicine [15]. WHO 
recommended the generic medicine 100% in the health care center. 
Unfortunately, the generic medicine was prescribed very low in 
private than public healthcare centers [16, 17].  
In era of NHI, The primary health care is the first place for the 
patient who use public insurance (NHI) should visit. Patients who 
had a serious health problem will rever to hospital that have better 
facilities. Therefore, only the selected drug was available in this 
place, mainly the first choice for hypertension [12]. All 
antihypertensive was found in this study were included the first 
choice for hypertention. The first choice antihypertensive by JNC 8 
[12]and European Society of Hypertension (ESH) and the European 
Society of Cardiology (ESC) [13] were angiotensin converting 
enzyme (ACEI), such as captopril, Ca channel blocker (CCB) as 
amlodipine and nifedipine, and diuretic hydrochlorothiazide. 
However, Angiostensin Reseptor Blocker is the first choice for 
hypertension too; this medicine was not available in primary health 
care centre. 
The availability of drug higher than the drug used, with estimated 
only 30% drug used every year. The stock of drug in the end of the 
month became availability for the first next month. After NHI, the 
percentage drug used and availability increased due to the number 
of patients visit increased as well. 
The demand of antihypertensive drug depend on the trend drug 
used. For example, hydrochlorothiazide was the highest available 
drug 1 y before NHI. Unfortunately, the drug used less. Therefore, 
the percentage drug used and availability became down. The 
demand of this drug became lower in the first year of NHI.  
The captopril and amlodipine were frequently prescribed due to the 
patients prefer to use it. The most frequency of antihypertensive 
drug used was captopril 12.5 mg and 25 mg and Nifedipine tab 10 
mg. These drugs were very popular among other antihypertensive 
drugs. One study in Spanish found that there is no different efficacy, 
side effect, and quality of life among patients using ACEIs and CCB in 
primary health care centre [18]. In China, the most frequency of 
antihypertensive used was CCB [19]. In another drug utilization 
study, 645 prescriptions were analyzed. A total of 697 
antihypertensive drugs prescribed, of which 33.57 % were ARBs, 
16.79 % ACEIs, 13.63 % were BBs and 11.91 % CCBs. About 32 % of 
the antihypertensives prescribed were from the essential medicine 
list [20]. In Jordan, ACEI were the most commonly prescribed 
monotherapy [21]. Jarary et. al (2016) also found a similar result 
[22]. The different finding in Eastern Ethiopia, the most frequently 
prescribed class of antihypertensive drugs, was diuretics [23]. 
The implementation of NHI also had impact to the availability, stock 
of drug, and the usage of antihypertensive drug predominantly in 
the first year of NHI implemented. For example, the availability of 
amlodipine 5 mg and 10 mg tablet, captopril 12.5 mg tablet 
increased significantly (P<0.05) after NHI was implemented. It was 
caused these drugs were the most frequency used. Moreover, 
hydrochlorothiazide decreased (P<0.05) as well due to the 
availability this drug was very high before NHI. The percentage 
medicine used compared the availability was very low. It was only 
3%. Therefore, the demand of this drug was limited after NHI. All 
stock of antihypertensive except captopril 25 mg tab different 
significantly (P<0.05) after the application of NHI. Captopril 25 mg 
tab was the most frequently prescribed in this study. The trend of 
availability, stock, and usage of this medicine was slightly increased 
but not different statistically. Therefore, the stock of medicine was 
persistent as well.  
The finding medicine increased after NHI due to the number of 
patients who visited primary health care raised as well. The 
curiosity of citizen also supported the increase of drug. The 
government was not allowed patients to visit directly the second 
health care centre, such as hospital. Therefore the number of 
patients increased significantly in the first health care centre.  
CONCLUSION 
The availability and usage of amlodipine, hydrochlorothiazide, and 
captopril 12.5 mg tab were significantly different after NHI. The 
usage of amlodipine, hydrochlorothiazide increased significantly but 
the consumed of nifedipine decreased. All stock of hypertensive drug 
except captopril 25 mg tab changed significantly after NHI. This 
study clearly indicated NHI impacted to the availability, usage, and 
stock of antihypertensive drugs in the primary health care centre 
site in Indonesia.  
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